DaVita (NYSE:DVA) 株価情報

DaVita

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Analyst Ratings

最新四半期、6人のアナリストがDaVita（NYSE:DVA）について格付を提供し、それによって楽観的と悲観的な視点が混在した結果が明らかになった。
以下の表は、アナリストたちの最新の評価を簡単にまとめたもので、過去30日間のセンチメントの変化を示しており、それを前月と比較している。




楽観的
やや楽観的
無関心
やや悲観的
悲観的




総合評価
2
0
4
0
0


最新30日
0
0
1
0
0


1カ月前
0
0
0

6人のアナリストがダビータを評価|投資家センチメントを分析

DaVita Inc

BrandywineGLOBAL-Dynamic US Large Cap Value ETF

Dovarri Inc

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies Corp

DaVita (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) affirms FY2025 Adj EPS guidance from $10.20-$11.30 to $10.20-$11.30 vs $10.89 analyst estimate..

News

Guidance

DaVita Affirms FY2025 Adj EPS Guidance of $10.20-$11.30 vs $10.89 Est

DaVita (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) reported quarterly earnings of $2.00 per share which beat the analyst consensus estimate of $1.95 by 2.56 percent. This is a 15.97 percent decrease over earnings of $2.38 per share from the same period last year. The company reported quarterly sales of $3.22 billion which beat the analyst consensus estimate of $3.21 billion by 0.53 percent. This is a 4.98 percent increase over sales of $3.07 billion the same period last year.

Earnings

Earnings Beats

DaVita Q1 Adj. EPS $2.00 Beats $1.95 Estimate, Sales $3.22B Beat $3.21B Estimate

U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of major benchmark indices were trading over 2% in premarket.
U.S. and China announced a <a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">90-day truce</a> to pause the reciprocal tariffs on Monday and revised it from 125% to 10%.&nbsp;This comes after the White House and Chinese officials signaled significant <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">headway in trade negotiations</a> held in Geneva over the weekend.
The U.S. will maintain its 20% tariffs on Chinese imports linked to fentanyl, keeping the overall tariff level on China at 30%. "We had very productive talks and I believe that the venue, here in Lake Geneva, added great equanimity to what was a very positive process,&#8221; said the Treasury Secretary Scott Bessent after the talks.
The U.S.-China joint statement also indicated Beijing&#8217;s agreement to suspend or remove all non-tariff countermeasures implemented since April 2, including sanctions on specific U.S. firms and export limits on crucial minerals, according <a href="https://www.scmp.com/economy/global-economy/article/3309975/china-us-reduce-majority-tariffs-after-first-round-trade-talks?module=top_story&amp;pgtype=homepage">to</a> the South China Morning Post.
Meanwhile, the 10-year Treasury bond yielded 4.44% and the two-year bond was at 3.98%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 92.1% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>2.12%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>2.76%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>3.68%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>3.16%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were slightly higher in premarket on Monday. The SPY was up 2.74% to $579.80, while the QQQ advanced 3.81% to $506.54, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Energy, real estate, consumer discretionary, and materials sectors advanced on Friday. While health care, communication services, consumer staples, and information technology sectors declined.
On the company-specific front, EchoStar Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) rose 1.43% on Friday after reporting quarterly sales of $3.87 billion, down 3.6% year-over-year, in line with the Street view.
Plains All American Pipeline LP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) fell nearly 3% after it reported first-quarter revenue of $12.011 billion, missing the consensus of $14.26 billion. Adjusted EPS was 39 cents, missing the consensus of 43 cents.
The Dow Jones index declined 119 points or 0.29% to 41,249.38, whereas the S&amp;P 500 index fell 0.071% to 5,659.91. Nasdaq Composite ended 0.004% higher at 17,928.92, and the small-cap gauge, Russell 2000, dropped 0.16% to 2,023.07.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.004%</td>
<td>17,928.92</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.071%</td>
<td>5,659.91</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.29%</td>
<td>41,249.38</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.16%</td>
<td>2,023.07</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
After last week, 90% of the S&amp;P 500 companies have reported quarterly results, and the performance has been strong relative to expectations, said Brian Therien, the investment strategist at Edward Jones.
Seventy-eight percent have beaten analyst estimates, with an average upside surprise of 8.6%, he highlighted. Forecasts for first-quarter earnings growth of S&amp;P 500 companies have been revised higher to 13.2%, from 6.7% at the end of the quarter.
Performance has been broad, with eight of the 11 sectors forecast to report higher earnings year-over-year.
&#8220;Wider earnings growth should drive more balanced market performance across sectors, strengthening the case for portfolio diversification, in our view,&#8221; Therien added.
Charles Schwab said in a note that they are maintaining a neutral &#8220;marketperform&#8221; rating on all sectors, a shift it made in April after the White House announced broad-reaching tariffs on imports.
&#8220;Uncertainty about the ultimate level and timing of the tariffs has made it difficult to assert a view on which sectors might outperform or underperform the S&amp;P 500 index, so we are holding all sector ratings at Marketperform until we have more clarity on trade policy,&#8221; the note stated.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul class="wp-block-list">
<li>On Monday, Fed Governor Adriana Kugler will speak at 10:20 a.m., and April&#8217;s monthly U.S. federal budget data will be released by 2:00 p.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>On Tuesday, April&#8217;s NFIB optimism index will be out by 6:00 a.m., whereas headline and core CPI data for April will be released by 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>On Wednesday, Fed Governor Christopher Waller will speak at 5:15 a.m., Fed Vice Chair Philip Jefferson will speak at 9:10 a.m., and San Francisco Fed President Mary Daly will speak at 5:40 p.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>On Thursday, the initial jobless claims data for the week ended May 10 will be out by 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>April&#8217;s U.S. retail sales, core and headline producer price index, May&#8217;s Empire State manufacturing survey, and Philadelphia Fed manufacturing survey will also be announced at 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>Fed Chairman Jerome Powell will speak at 8:40 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>April&#8217;s industrial production and capacity utilization will be out by 9:15 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>March&#8217;s business inventories data and May&#8217;s home builder confidence index will be released by 10:00 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>Fed Governor Michael Barr will speak at 2:05 p.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>On Friday, April&#8217;s import price index, housing starts, and building permit data will be released by 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>The preliminary consumer sentiment for May will be released by 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Fox Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) rose 0.52% in premarket on Monday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of 91 cents per share on the revenue of $4.18 billion.</li>
</ul>
<ul class="wp-block-list">
<li>NRG Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) jumped 3.08% as Wall Street expects it to report earnings of $1.49 per share on revenue of $7.83 billion. before the opening bell.</li>
</ul>
<ul class="wp-block-list">
<li>Southwest Gas Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWX#NYSE">SWX</a>) dropped 4.85% ahead of its earnings. Analysts expect earnings of $1.50 per share on revenue of $1.50 billion.</li>
</ul>
<ul class="wp-block-list">
<li>Davita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) was up 2.94% as Wall Street expects it to report earnings of $1.95 per share on revenue of $3.21 billion after the closing bell.</li>
</ul>
<ul class="wp-block-list">
<li>Hawaiian Electric Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) was 0.095% above the flatline after it reported first-quarter earnings of 23 cents per share, in line with market estimates. The company reported $744.07 million in sales during the quarter.</li>
</ul>
<ul class="wp-block-list">
<li>Rio Tinto PLC ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) was up 2.93% after it signed a definitive agreement for the Winu project joint venture with Sumitomo Metal Mining.</li>
</ul>
<ul class="wp-block-list">
<li>Pan American Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) slumped 6.65% after announcing an agreement to acquire MAG Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAG#NYSE">MAG</a>), which was up 6.62% in premarket.</li>
</ul>
<ul class="wp-block-list">
<li>Alibaba Group Holding Ltd. ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) was up 7.18%, JD.Com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) jumped 6.05%, Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) advanced 4.64%, whereas PDD Holdings Inc. ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) gained 8.24% along with other Chinese peers amid the ongoing U.S.-China talks on tariff reductions.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 2.85% to hover around $62.76 per barrel.
Gold Spot US Dollar fell 2.74% to hover around $3,233.54 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 1.10% at the 101.4460 level.
Asian markets ended higher on Monday as India's S&amp;P BSE Sensex, South Korea's Kospi, China&#8217;s CSI 300, Japan's Nikkei 225, Australia's ASX 200, and Hong Kong's Hang Seng index rose. European markets were also higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45340465/bill-ackman-slams-subsidies-for-contributing-to-37-trillion-national-debt-hails-trumps-drug-price-order">Bill Ackman Slams Subsidies For Contributing To $37 Trillion National Debt, Hails Trump&#8217;s Drug Price Order </a></li>
</ul>
Image via Shutterstock

Analyst Color

Asia

Earnings Misses

Equities

Government

Macro Economic Events

Macro Notification

Market Summary

Regulations

Bonds

Broad U.S. Equity ETFs

Emerging Markets

Eurozone

Futures

Commodities

Forex

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

ETFs

General

BABA

BIDU

FOXA

PAAS

Citigourp Global Markets 2% Protected Notes Linked To The Djia

SATS

US Stock Futures Rise As US, China Agree To 90-Day Tariff Pause: 'Wider Earnings Growth Should Drive More Balanced Market Performance,' Says Expert

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 100 during the session ahead of trade talks between the US and Chinese officials.
Major indices on the US also closed lower last week, with the S&amp;P 500 falling about 0.5% and the Nasdaq down around 0.3%. The Dow also declined almost 0.2% in the week.
Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) reported better-than-expected earnings for the first quarter and announced a $750 million share buyback plan on Thursday. EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) reported wider-than-expected loss for the first quarter on Friday.
On the economic data front, U.S. initial jobless claims declined by 13,000 to 228,000 in the week ending May 3, compared to market estimates of 230,000. U.S. labor productivity in the nonfarm business sector declined by 0.8% during the first quarter compared to estimates of a 0.7% drop.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, consumer discretionary and energy stocks recording biggest gains on Friday. However, health care and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 119 points to 41,249.38 on Friday. The S&amp;P 500 fell 0.07% to 5,659.91, while the Nasdaq Composite gained 0.01% at 17,928.92 during Friday's session.
Investors are awaiting earnings results from DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) and NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) today.
At a current reading of 61.6, the index was in the &#8220;Greed&#8221; zone on Friday, versus a prior reading of 61.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Trading Ideas

LYFT

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone

ACHC

ACHR

ACNT

AGEN

AIRJ

ALLT

ALTI

AMBC

AMPY

APEI

AQST

ARCT

ARWR

ASRT

ASYS

AUPH

BATRA

BATRK

Mobile Infrastructure Corporation Common Stock

BEEP

BETR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLDE

BLNK

CATX

CEPU

CHGG

CHRS

CLLS

CLPR

CMCL

CMPO

CNNE

CNTY

CPSS

CTMX

CTRI

CWCO

DOLE

EDIT

EXOD

FGEN

FRPH

FTEK

FTRE

GAIA

GETY

GPRO

GRDN

HBIO

HFFG

HNRG

IHRT

IMNN

INDI

ISPR

KBDC

KPTI

KSPI

LAND

LEGH

LINC

LSEA

LTBR

METC

Ramaco Resources, Inc. - Class B Common Stock

METCB

MFIC

MLNK

MLYS

MNDY

MODG

MRVI

MVIS

MVST

NMRA

NOTE

NPWR

NRGV

NRXS

Earnings Scheduled For May 12, 2025

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Wall Street expects Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) to report quarterly earnings at 91 cents per share on revenue of $4.18 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Fox shares gained 1% to $47.20 in after-hours trading.</li>
<li>Hawaiian Electric Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) reported first-quarter earnings of 23 cents per share, in-line with market estimates. The company reported $744.07 million in sales during the quarter. Hawaiian Electric shares rose 0.1% to $10.50 in the after-hours trading session.</li>
<li>Analysts are expecting NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) to post quarterly earnings at $1.49 per share on revenue of $7.83 billion. The company will release earnings before the markets open. NRG Energy shares gained 1.4% to $121.03 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>After the closing bell, DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) is projected to post quarterly earnings at $1.95 per share on revenue of $3.21 billion. DaVita shares fell 0.4% to $143.15 in the after-hours trading session.</li>
<li>Analysts expect Southwest Gas Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWX#NYSE">SWX</a>) to report quarterly earnings at $1.50 per share on revenue of $1.50 billion. Southwest Gas shares fell 1.3% to $74.67 in after-hours trading.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Fox, NRG Energy And 3 Stocks To Watch Heading Into Monday

U.S. stock futures rose Sunday evening after weekend trade talks in Geneva signaled potential de-escalation in the ongoing trade war with China.
The S&amp;P 500 Futures are up 1.35%, trading at 5,754.50, Nasdaq Futures are trading at 20,515.25, up 1.88%, and finally Dow Jones Futures are up 1.01%, trading at 41,740.
On the other side of the Pacific, Japan&#8217;s Nikkei 225 index opened higher, and is trading at 37,611.66, up 0.29% at the time of writing this, led by real estate, tech exports, and semiconductor stocks, as fresh optimism on trade talks helped spur sentiments.
The White House announced progress on the deal in a post on X on Sunday. Treasury Secretary Scott Bessent hailed the &#8220;substantial progress&#8221; made between the two countries in what he called &#8220;very important trade talks.&#8221;
U.S. Trade Ambassador Jamieson Greer pointed out the quickness with which U.S. and China &#8220;were able to come to agreement.&#8221; He expressed confidence that the deal that was struck would help the U.S. with the &#8220;national emergency&#8221; that was the massive $1.2 trillion trade deficit.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: U.S. Announces China Trade Deal in Geneva <a href="https://t.co/JjgvYAvAGe">pic.twitter.com/JjgvYAvAGe</a>
&mdash; The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1921623939060519353?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See More: <a href="https://www.benzinga.com/25/05/45338985/trump-reportedly-set-to-accept-flying-palace-from-qatar-white-house-says-lavish-gift-of-boeing-jumbo-jet-complies-with-all-applicable-laws">Trump Reportedly Set To Accept &#8216;Flying Palace&#8217; From Qatar, White House Says Lavish Gift Of Boeing Jumbo Jet Complies With &#8216;All Applicable Laws&#8217;</a>
The U.S. Dollar Index (DXY) continued its rally on Sunday evening, up 0.26%, trading at 100.67, following hopes of trade deals and the Fed&#8217;s decision last week to keep <a href="https://www.benzinga.com/25/05/45314594/asia-markets-mixed-eurozone-gains-oil-rises-on-trade-deal-hopes-global-markets-today-while-us-slept">interest rates steady</a>.
On Sunday, the Chinese delegation also announced that both sides had reached an &#8220;important consensus&#8221; during the ongoing trade talks in Geneva. While neither side has released any details yet, Chinese Vice Commerce Minister Li Chenggang was quoted as saying that the outcome would be &#8220;good news for the world,&#8221; according to a report by Reuters.
According to Bessent and Greer, the details of this &#8220;substantial progress&#8221; will be announced on Monday.
Investors on Monday will also be closely watching the earnings of NRG Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>), Monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>), and DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>). Fed Governor Adriana Kugler&#8217;s speech early in the day, alongside the monthly U.S. Federal Budget, will be monitored. 
Photo Courtesy: Tomas Ragina On Shutterstock.com
Read More: <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">Trump Announces &#8216;Total Reset&#8217; as US-China Trade Talks Aim to End Tariff War</a>

Dow Futures Rally Over 400 Points As US, China 'Come To Agreement' In Geneva Trade Talks

DaVita (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release.
Analysts are estimating that DaVita will report an earnings per share (EPS) of $2.08.
The announcement from DaVita is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.10, leading to a 11.09% drop in the share price the following trading session.
Here's a look at DaVita's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.14</td>
<td>2.73</td>
<td>2.54</td>
<td>1.95</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.24</td>
<td>2.59</td>
<td>2.59</td>
<td>2.38</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-11.0%</td>
<td>-11.0%</td>
<td>-2.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746799295_0.png" alt="eps graph" />
<h3>Tracking DaVita's Stock Performance</h3>
Shares of DaVita were trading at $143.63 as of May 08. Over the last 52-week period, shares are up 5.06%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on DaVita</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on DaVita.
The consensus rating for DaVita is Neutral, derived from 1 analyst ratings. An average one-year price target of $169.0 implies a potential 17.66% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Hims &amp; Hers Health, Chemed and Option Care Health, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Hims &amp; Hers Health, with an average 1-year price target of $37.11, suggesting a potential 74.16% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Chemed, with an average 1-year price target of $670.5, suggesting a potential 366.82% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Option Care Health, with an average 1-year price target of $38.5, suggesting a potential 73.2% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Hims &amp; Hers Health, Chemed and Option Care Health are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>DaVita</td>
<td>Neutral</td>
<td>4.73%</td>
<td>$1.07B</td>
<td>102.13%</td>
</tr>
<tr>
<td>Hims &amp; Hers Health</td>
<td>Neutral</td>
<td>110.67%</td>
<td>$430.69M</td>
<td>9.65%</td>
</tr>
<tr>
<td>Chemed</td>
<td>Outperform</td>
<td>9.79%</td>
<td>$216.41M</td>
<td>6.24%</td>
</tr>
<tr>
<td>Option Care Health</td>
<td>Outperform</td>
<td>16.31%</td>
<td>$263.05M</td>
<td>3.39%</td>
</tr>
</tbody>
</table>

Key Takeaway:
DaVita ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
<h3>About DaVita</h3>
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
<h3>A Deep Dive into DaVita's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining DaVita's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.73% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: DaVita's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 7.87%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 102.13%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): DaVita's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.49%, the company showcases efficient use of assets and strong financial health.
Debt Management: DaVita's debt-to-equity ratio is notably higher than the industry average. With a ratio of 99.63, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<a href="https://www.benzinga.com/quote/DVA/earnings">To track all earnings releases for DaVita visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For DaVita

These large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) stock dipped 23.60% after the company reported worse-than-expected first-quarter results and cut its FY25 adjusted <a href="https://www.benzinga.com//node/44860240" target="_blank" rel="noreferrer noopener">EPS guidance below estimates</a>.</li>
<li>Global Payments Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) shares declined 16.55% after the company announced it had bought a <a href="https://www.benzinga.com//node/44862867" target="_blank" rel="noreferrer noopener">stake in Worldpay for $6.6 billion</a>.</li>
<li>Applovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) stock decreased 9.71% after Goldman Sachs analyst Eric Sheridan cut its price <a href="https://www.benzinga.com/quote/app/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast from $500 to $335</a>.</li>
<li>Humana Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) stock was down 8.88% on pin action after UnitedHealth Group, Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported worse-than-expected <a href="https://www.benzinga.com//node/44860240" target="_blank" rel="noreferrer noopener">first-quarter results</a>.</li>
<li>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) shares fell 8.69% in the last week.</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) stock declined 8.20% amid <a href="https://www.benzinga.com//node/44821791" target="_blank" rel="noreferrer noopener">the FTC&#8217;s antitrust trial</a>. Several analysts lowered the <a href="https://www.benzinga.com/quote/meta/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares dived 7.70%.</li>
<li>CoreWeave, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) stock was down 7.37%.</li>
<li>Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) shares fell 6.97% amid overall market weakness after Fed Chair Powell made remarks at the Economic Club.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares declined 6.46% after JP Morgan analyst Samik Chatterjee cut its price forecast on the <a href="https://www.benzinga.com/quote/smci/analyst-ratings" target="_blank" rel="noreferrer noopener">stock from $45 to $39</a>.</li>
<li>GlobalFoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) shares declined 6.24% after NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) said the US government recently informed that it would need a <a href="https://www.benzinga.com//node/44856114" target="_blank" rel="noreferrer noopener">license to export chips to China</a>.</li>
</ol>
Photo via Shutterstock

Large Cap

Movers

BURL

CRWV

NVDA

RDDT

SMCI

YUMC

These Large Cap Tech And Healthcare Stocks Had A Poor Run In Easter Week (Apr 14-Apr 18): Are These In Your Portfolio?

Wall Street pared early morning gains by midday Monday, as investor caution returned despite a temporary easing in U.S.-China trade tensions. While the initial market reaction was positive, especially in tech, enthusiasm faded as <a href="https://www.benzinga.com/markets">the trading session progressed.</a>
Over the weekend, the White House announced a provisional exemption for smartphones and semiconductors from China&#8217;s proposed 145% trade tariff. These items will instead face a 20% levy—linked to fentanyl-related enforcement—until sector-specific duties are finalized.
The development triggered a strong premarket rally in technology stocks. Yet, those gains were sharply trimmed by midday amid broader geopolitical and policy concerns.
During a White House meeting with El Salvador President Nayib Bukele, President Donald Trump said he plans to impose tariffs on pharmaceutical imports to boost domestic manufacturing. 
He reiterated a hardline stance on Iran, warning of severe consequences if Tehran develops nuclear weapons, but also suggested &#8220;flexibility&#8221; in tariff negotiations, emphasizing a desire not to harm U.S. businesses.
Defensive and domestic-oriented sectors such as real estate, utilities, and consumer staples outperformed broader markets. In contrast, consumer discretionary was the only sector trading in negative territory.
Treasury yields dropped significantly, reflecting increased demand for U.S. government debt and easing fears of foreign liquidation. The 2-year yield fell 10 basis points to 3.87%, while 10-year benchmark yield dropped 7 basis points to 4.42%.
Gold pulled back 1% to $3,200 per ounce, pausing after a three-session rally. Crude oil fell 0.8% to $61 per barrel, while natural gas slid 2.9% to $3.39 per MMBtu, eyeing its lowest level since last Wednesday.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was little changed at $84,000, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) gained 2.1% to $1,630.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,326.49</td>
<td>0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,377.08</td>
<td>0.3%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,695.41</td>
<td>0.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,856.16</td>
<td colspan="2">-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:30 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.5% up to $537.23.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.4% to $403.81.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) edged 0.4% higher to $454.38.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.1% higher to 184.74.</li>
<li>The&nbsp;Real Estate&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) outperformed, up 1.9%; the&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 0.5%.</li>
</ul>
In company news, Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) reported stronger-than-expected earnings during the first quarter, and shares rose 1.9%.
<h3 class="wp-block-heading">S&amp;P 500&#8217;s Top 5 Gainers On Monday</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company </th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>)</td>
<td>6.91%</td>
</tr>
<tr>
<td>Charles River Laboratories Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>)</td>
<td>5.98%</td>
</tr>
<tr>
<td>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)</td>
<td>4.69%</td>
</tr>
<tr>
<td>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>)</td>
<td>4.64%</td>
</tr>
<tr>
<td>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)</td>
<td>4.15%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">S&amp;P 500&#8217;s Worst 5 Losers On Monday</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>)</td>
<td>-3.80%</td>
</tr>
<tr>
<td>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>)</td>
<td>-3.61%</td>
</tr>
<tr>
<td>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td>-3.04%</td>
</tr>
<tr>
<td>Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>)</td>
<td>-2.39%</td>
</tr>
<tr>
<td>Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>-2.36%</td>
</tr>
</tbody>
</table>
</figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/04/44794083/7-chipmaker-stocks-set-to-gain-as-trump-delays-tariff-blow-on-key-china-tech-imports-bank-of-america">7 Chipmaker Stocks Set To Gain As Trump Delays Tariff Blow On Key China Tech Imports: Bank Of America</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Econ #s

Tech

$BTC

$ETH

AMZN

SPDR Dow Jones Industrial Average ETF Trust

ENPH

FSLR

PLTR

SNDK

XLRE

Select Sector SPDR-Consumer Discretionary

Wall Street Pulls Back After Early Gains As Tariff Uncertainties Persist: What's Driving Markets Monday?

On April&nbsp;12, 2025, DaVita Inc. (the "Company" or "we") became aware of a ransomware incident that has encrypted certain elements of our network. Upon discovery, we activated our response protocols and implemented containment measures, including proactively isolating impacted systems. We are actively working to assess and remediate the incident with the assistance of third-party cybersecurity professionals and have notified law enforcement of the matter.
We have implemented our contingency plans, and we continue to provide patient care. However, the incident is impacting some of our operations, and while we have implemented interim measures to allow for the restoration of certain functions, we cannot estimate the duration or extent of the disruption at this time.
Given the recency of the incident, our investigation and response are ongoing, and the full scope, nature, and potential ultimate impact on the Company are not yet known.

DaVita Responds to Cyberattack, Isolates Affected Systems as Investigation into Ransomware Incident Continues

David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs, has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends.
What Happened: On CNBC&#8217;s &#8216;Squawk on the Street&#8217;, Kostin discussed his revised earnings growth forecast and market trends. Initially projected at 11%, the earnings growth forecast for 2025 has now been adjusted to 9%. 
Despite this, Kostin maintains that the earnings growth for 2026 remains at 7%, unchanged. He also stated that the S&amp;P 500 year-end target remains at 6500, suggesting an 11% gain from current levels.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Goldman Sachs&#039; Kostin: We&#039;re revising EPS growth forecast lower, but healthcare poses opportunity" width="500" height="281" src="https://www.youtube.com/embed/Pn9ySR9ygao?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Kostin also noted a shift in investment strategy, with investors moving from &#8220;excitement&#8221; (cyclicals) to &#8220;boredom&#8221;&nbsp;(defensive stocks) amid tariff&nbsp;uncertainties. He identified healthcare and consumer staples as preferred sectors for their stability and less sensitivity to the ongoing trade war. He also named&nbsp;Thermo Fisher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) and Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) as strong investment options. 
Furthermore, he notes a shift in focus from AI infrastructure and hyperscalers to software companies that would be leveraging AI to amplify their revenues, for instance, MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>). 
According to Kostin, uncertainty around tariffs makes forecasting difficult, but models suggest&nbsp;earnings will be impacted through unit volumes and margins. The strategist estimated that a 5% increase in tariffs&nbsp;could reduce earnings growth by&nbsp;1-2%.
SEE ALSO: <a href="https://www.benzinga.com/general/space/25/03/44102170/spacex-scraps-starship-flight-test-on-monday-too-many-question-marks-about-this-flight-says-ceo-elon-musk">SpaceX Scraps Starship Flight Test On Monday: &#8216;Too Many Question Marks About This Flight&#8230;,&#8217; Says CEO Elon Musk</a>
Why It Matters: This shift in investment strategy is noteworthy, considering that institutional investors were bullish on technology and financials during the fourth quarter of 2024. Investors were seen <a href="https://www.benzinga.com/markets/equities/25/02/43878703/institutional-investors-load-up-on-technology-and-financial-stocks-in-q4-while-reducing-positions-in-healthcare-sector-amid-political-uncertainty">pulling back</a> from the healthcare sector, which Kostin now identifies as a preferred sector. Even Warren Buffet&#8216;s Berkshire Hathaway trimmed its stake in healthcare provider DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), bringing down the ownership to 45%.
These market shifts and Kostin&#8217;s revised forecast underline the uncertainties in the current economic climate but also highlight potential&nbsp;opportunities in defensive sectors and&nbsp;AI-driven businesses. That being said, Kostin expects the falling bond yields to offset some tariff effects, potentially benefiting the economy. He summed up by saying that GDP growth is the primary driver of earnings, with interest rates and inflation playing secondary roles.
The S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) climbed 1.12% to close at 5,842.63 on Wednesday after President Donald Trump pushed back auto tariffs on Canada and Mexico by one month.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/03/44159766/us-indicts-12-chinese-nationals-over-alleged-global-hacking-operation-targeting-critics-been-paying-hackers-for-hire-to-inflict-digital-harm-on-americans">US Indicts 12 Chinese Nationals Over Alleged Global Hacking Operation Targeting Critics: &#8216;&#8230;Been Paying Hackers-For-Hire To Inflict Digital Harm On Americans&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom'

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) stock fell 23.01% following weak FY25 guidance. Several analysts lowered the <a href="https://www.benzinga.com/quote/sfm/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) shares fell 22.79% after Craig-Hallum analyst Jeremy Hamblin downgraded the stock from Buy to Hold and <a href="https://www.benzinga.com/quote/axon/analyst-ratings" target="_blank" rel="noreferrer noopener">announced a $625 price forecast</a>.</li>
<li>Twilio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) shares tumbled 22.39% after the company reported mixed fourth-quarter results and analysts revised <a href="https://www.benzinga.com//node/43742521" target="_blank" rel="noreferrer noopener">forecasts on the stock</a>.</li>
<li>EPAM Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) stock declined 21.97% following its fourth-quarter and full-year 2024 earnings report <a href="https://www.benzinga.com//node/43867480" target="_blank" rel="noreferrer noopener">and disappointing 2025 guidance.</a></li>
<li>Nu Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) stock decreased 21.54% following the company's<a href="https://www.benzinga.com//node/43869101" target="_blank" rel="noreferrer noopener"> fourth-quarter financial results</a>.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) lost 21.18% as the software company's stocks fell amid overall market weakness on U.S. consumer and economic concerns.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) stock lost 21.04% last week. The stock reversed its gains following an <a href="https://www.benzinga.com//node/43883117" target="_blank" rel="noreferrer noopener">agreement in principle with SEC staff</a> to drop the case against the company.</li>
<li>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) shares dipped 19.58%. Warren Buffett's investment firm, Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), has offloaded a 2% stake in the company, with the transaction <a href="https://www.benzinga.com//node/43874883" target="_blank" rel="noreferrer noopener">valued at around $116 million</a>.</li>
<li>Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) stock lost 19.12% as broader financial sector stocks fell amid overall market weakness on U.S. consumer and economic concerns.</li>
<li>Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares declined 18.81%. Piper Sandler analyst Thomas Champion maintained an Overweight rating and raised the <a href="https://www.benzinga.com/quote/rddt/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast from $210 to $220</a>.</li>
</ol>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/02/43902979/alibaba-super-micro-computer-and-xpeng-are-among-top-10-large-cap-gainers-last-week-feb-17-feb-21-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Alibaba, Super Micro Computer And XPeng Are Among Top 10 Large Cap Gainers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Topics

AKAM

AXON

COIN

EPAM

HOOD

TWLO

Twilio, Coinbase And Reddit Are Among Top 10 Large Cap Losers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?

Warren Buffett&#8216;s investment firm, Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), has offloaded a 2% stake in dialysis service provider, DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>). The transaction, executed between February 14 and 19, is valued at around $116 million.
What Happened: A Form 4 filing with the&nbsp;U.S. Securities and Exchange Commission&nbsp;(SEC) on Wednesday night revealed that Berkshire Hathaway sold 750,000 DaVita shares, in multiple batches, bringing its stake in the company down to 35.14 million shares, or approximately 44%. This follows a <a href="https://www.benzinga.com/general/market-summary/25/02/43721022/warren-buffetts-berkshire-hathaway-sells-nearly-36-million-worth-of-dialysis-giant-davitas-shares-amid-q4-earnings-beat">previous sale of 203,091 shares </a>on February 11, which reduced Berkshire&#8217;s ownership to 45%.
The latest transaction is categorized as an insider trade, differing from the earlier trade&nbsp;related to a share buyback&nbsp;agreement. These sales are a part of Berkshire&#8217;s continuous portfolio management approach, but the real reason behind the sale has not been disclosed. 
Despite the recent sales, the Buffet-led company continues to be a majority owner of DaVita, holding 35.14 million shares worth approximately $5.4 billion. According to Reuters, Berkshire has been a DaVita investor since the last quarter of 2011.
SEE ALSO: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43874379/dogecoin-millionaire-pushes-conviction-plays-like-pepe-like-theres-no-tomorrow-best-time-to-start-buying">Dogecoin &#8216;Millionaire&#8217; Pushes &#8216;Conviction Plays&#8217; Like PEPE Like There&#8217;s No Tomorrow: &#8216;Best Time To Start Buying&#8217;</a>
Why It Matters: The recent sale of DaVita shares by Berkshire Hathaway follows a previous sale on February 11 which brought Berkshire&#8217;s stake in the company down to 45%.
On February 14, <a href="https://www.benzinga.com/general/health-care/25/02/43725529/davita-plunges-over-10-in-friday-pre-market-after-warren-buffett-cuts-stake-in-one-of-berkshire-hathaways-longest-held-investments">DaVita's stock price dropped over 11% following</a> the company&#8217;s earnings beat but a disappointing outlook for Fiscal 2025. The company projected full-year EPS between $10.20 and $11.30, falling short of the analysts&#8217; average expectation of $11.44. &nbsp;
Shortage of intravenous fluid, elevated mortality rates, and regulatory changes are some of the challenges that the company has been grappling with recently. Javier Rodriquez, CEO of DaVita acknowledged the challenges and stated, &#8220;Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range.&#8221;
Meanwhile, according to StreetInsider, Bernstein SocGen Group analyst Lisa Bedell Clive stated &#8216;We View the Results as Negative&#8217;. She reinforced a &#8216;Market Perform&#8217; rating and a price target of $184.00 on DaVita stock. 
That said, the shares of the kidney dialysis provider surged more than 20% over the past 12 months. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/asia/25/02/43872677/alibaba-cfo-toby-xu-touts-5-drop-in-share-count-thanks-to-aggressive-buybacks-as-jack-ma-founded-company-basks-in-stellar-q3-results">Alibaba CFO Toby Xu Touts 5% Drop In Share Count Thanks To Aggressive Buybacks As Jack Ma-Founded Company Basks In Stellar Q3 Results</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Warren Buffett's Berkshire Hathaway Sells $116M Shares Of Dialysis Giant DaVita, Cuts Stake By 2%

Barclays analyst Andrew Mok maintains DaVita (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) with a Equal-Weight and raises the price target from $164 to $169.

Price Target

Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $169

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Friday.
Shares of Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell sharply in today's pre-market trading after the company issued second-quarter revenue guidance <a href="https://in.benzinga.com/25/02/43715360/applied-materials-stock-slides-after-q1-report-weak-q2-revenue-guidance">below estimates</a>.
Applied Materials reported quarterly earnings of $2.38 per share which beat the $2.29 analyst consensus estimate. Quarterly revenue came in at $7.17 billion, beating the $7.14 billion consensus estimate. The company sees second-quarter earnings of $2.30 per share, plus or minus 18 cents, versus the $2.30 estimate and revenue of $7.1 billion, plus or minus $400 million, versus the $7.21 billion estimate.
Applied Materials shares tumbled 5.1% to $174.81 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Informatica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) shares dipped 35.6% to $16.21 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) declined 22.5% to $3.20 in pre-market trading after gaining 3% on Thursday.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 16.1% to $16.01 in pre-market trading after declining 5% on Thursday.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) shares fell 13.2% to $25.25 in pre-market trading following downbeat quarterly earnings.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) dipped 12.3% to $13.37 in pre-market trading. Nvidia reported it dissolved share stake in Soundhound in 13F.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) fell 8.6% to $134.49 in pre-market trading following weak first-quarter guidance.</li>
<li>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) fell 7.9% to $163.00 in pre-market trading after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market closed on Thursday.</li>
<li>Moderna, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) fell 6.3% to $29.89 in pre-market trading following fourth-quarter results.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 5.6% to $18.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

AMAT

INFA

MRNA

SLSR

SOUN

STVN

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session

WIIM

DaVita shares are trading lower after the company reported Q4 financial results.

The shares of DaVita Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market closed on Thursday.
What Happened: Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), the multinational conglomerate headed by Warren Buffett, <a href="https://www.benzinga.com/general/market-summary/25/02/43721022/warren-buffetts-berkshire-hathaway-sells-nearly-36-million-worth-of-dialysis-giant-davitas-shares-amid-q4-earnings-beat">sold off its 45% stake</a> or 203,091 shares in the company. This sale, which took place on February 11, has brought down the conglomerate&#8217;s holdings to approximately $6.4 billion, representing about 35.89 million shares.
Additionally, DaVita&#8217;s 2025 outlook missed Wall Street expectations, projecting full-year EPS between $10.20 and $11.30, lower than the analysts&#8217; average estimate of $11.44.
SEE ALSO:<a href="https://www.benzinga.com/markets/25/02/43722945/tech-war-intensifies-as-trump-sets-to-revise-the-us-chips-act-conditions-not-aligned-to-white-house-policies-under-review"> </a><a href="https://www.benzinga.com/markets/25/02/43722945/tech-war-intensifies-as-trump-sets-to-revise-the-us-chips-act-conditions-not-aligned-to-white-house-policies-under-review">Trump Administration Reevaluates CHIPS Act Grants, Potentially Delaying Semiconductor Funding: Report</a>
Why It Matters: Even as the company posted a weaker outlook, its fourth-quarter earnings and revenue exceeded expectations. The company reported adjusted earnings per share of $2.24 for Q4, exceeding the analyst consensus of $2.13. Revenue reached $3.3 billion, surpassing estimates of $3.26 billion.
CEO Javier Rodriguez expressed confidence: &#8220;Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range.&#8221; DaVita also anticipates supply dynamics to return to normal in the first quarter.
Meanwhile, the sale by Berkshire Hathaway was part of&nbsp;a share repurchase agreement, under&nbsp;which DaVita is committed to buying back enough shares every quarter to keep Berkshire&#8217;s stake at 45%. Berkshire Hathaway has been a shareholder in DaVita since the last quarter of 2011, as per Reuters.
DaVita stock closed 2.9% higher at $177.06 on Thursday. It surged more than 43% over the past year. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/equities/25/02/43721445/apple-tesla-and-other-mag-7-peers-too-expensive-top-hedge-fund-challenges-overvaluation-concerns-says-they-are-fairly-priced-if-they-sustain-20-earnings-growth-rate">Apple, Tesla And Other MAG 7 Peers Too Expensive? Top Hedge Fund Challenges &#8216;Overvaluation&#8217; Concerns, Says They Are Fairly Priced If They Sustain 20% Earnings Growth Rate</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Health Care

DaVita Plunges Over 10% In Friday Pre-Market After Warren Buffett Cuts Stake In One Of Berkshire Hathaway's Longest-Held Investments

Warren Buffett's Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) has cut its stake in the dialysis provide DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) according to a U.S. Securities Exchange Commission filing.
What Happened: According to the SEC filing, <a href="https://www.benzinga.com/25/02/43622036/warren-buffett-indicator-tops-205-amid-skyrocketing-sp-500-valuations-as-this-billionaire-dot-com-crash-predictor-sounds-alarm">Buffett</a>&#8216;s Berkshire sold 203,091 shares of DaVita on Feb 11. Based on the stock's Thursday closing price, the transaction was valued at $35.96 million. Berkshire now owns about 35.892 million shares in the company representing a 45% stake abiding by its earlier share repurchase agreement.
According to Reuters, Berkshire has owned DaVita since the fourth quarter of 2011.
DaVita reported its full-year and fourth-quarter earnings after markets closed on Thursday. For the year ending Dec. 31, 2024, the company reported consolidated revenue of $12.8 billion, with $3.3 billion generated in the fourth quarter beating <a href="https://www.benzinga.com/quote/DVA/earnings">Benzinga Pro estimate</a> of $3.27 billion.
Diluted earnings per share were $3.09 for the quarter and $10.73 for the year, while adjusted diluted earnings per share were $2.24, beating estimates of $2.14 for the quarter.
The company repurchased 2.3 million shares in the fourth quarter at an average price of $156.46 per share, and 9.8 million shares for the full year at an average price of $140.06 per share.
See Also: <a href="https://www.benzinga.com/government/regulations/25/02/43692006/donald-trumps-favorite-word-tariffs-is-the-reason-why-us-coke-and-pepsi-does-not-have-sugar-but-high-fructose-corn-syrup">Reagan&#8217;s Sugar Quotas, Trump&#8217;s Tariffs, And The Price Of Protectionism: Here&#8217;s Why Coke And Pepsi In US Have High Fructose Corn Syrup Instead Of Sugar</a>
Why It Matters: As previously reported in a Form 8-K filed on May 1, 2024, DaVita entered into a Share Repurchase Agreement with Berkshire, the company's largest stockholder, as of April 30, 2024.
Under the agreement, if Berkshire owns at least 45% of DaVita's stock, DaVita will buy back shares from Berkshire quarterly to maintain Berkshire&#8217;s ownership at 45%.
The 2024 filing stated that if Berkshire's ownership exceeds 49.5%, DaVita will repurchase shares immediately. Additionally, Berkshire agreed to vote any shares it owns above 40% according to DaVita's board recommendations.
This agreement does not change the existing Amended Standstill Agreement. Thus, DaVita repurchased its shares to bring back Berkshire&#8217;s holdings to 45% on Feb. 11, ahead of its on Feb. 13.
Price Action: DaVita shares gained 2.94% on Thursday, reaching $177.06 per share, but dropped 6.87% in after-hours trading as the company provided a weak outlook for 2025. DaVita projected a full-year EPS of $10.20 to $11.30, falling short of Wall Street's expectation of $11.44 per share.
The exchange-traded fund tracking the S&amp;P 500 index, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1.06% on Thursday. DVA has risen 18.18% year-to-date, whereas it gained 43.47% over the last year.
The average price target among nine <a href="https://www.benzinga.com/quote/DVA/analyst-ratings">analysts tracked by Benzinga</a> is $138.33 with a ‘sell&#8217; rating. The estimates range from $90 to $175 apiece. Recent ratings from Barclays, Truist Securities, and Truist Securities suggest a $168 target, implying a potential upside of 1.89%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/DVA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="383" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14004226/DVA-ANR-1024x383.png" alt="" class="wp-image-782329" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14004226/DVA-ANR-1024x383.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14004226/DVA-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14004226/DVA-ANR-768x287.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14004226/DVA-ANR.png 1051w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43688600/exclusive-michael-saylors-mstr-linked-etfs-are-not-for-long-term-investors-say-crypto-experts-they-also-double-the-potential-loss">[Exclusive] Michael Saylor&#8217;s MSTR-Linked ETFs Are &#8216;Not For Long-Term Investors&#8217; Say Crypto Experts: &#8216;…They Also Double The Potential Loss&#8217;</a></li>
</ul>

Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat

Comments

DaVita

ニュース

パートナーシップ

ベンジンガ・グローバル